Effects of prednisolone on skeletal muscle contractility in mdx mice. - Wikidata - awgldk - TriplyDB

Effects of prednisolone on skeletal muscle contractility in mdx mice.

Effects of prednisolone on skeletal muscle contractility in mdx mice.

http://www.wikidata.org/entity/Q33887318

about

Low intensity, high frequency vibration training to improve musculoskeletal function in a mouse model of Duchenne muscular dystrophy Exercise training improves plantar flexor muscle function in mdx mice.Bone is functionally impaired in dystrophic mice but less so than skeletal muscle.Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actin The myosin super-relaxed state is disrupted by estradiol deficiency.TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.Influence of ovarian hormones on strength loss in healthy and dystrophic female mice.Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment Adaptations of mouse skeletal muscle to low-intensity vibration training.Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents Skeletal muscle contractile function and neuromuscular performance in Zmpste24 -/- mice, a murine model of human progeria.A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.Microtubule binding distinguishes dystrophin from utrophin.What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?Overview of the Muscle Cytoskeleton.Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes.Plantarflexion contracture in the mdx mouse.Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy.Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice.Progressive resistance voluntary wheel running in the mdx mouse.Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.Deletion of estrogen receptor alpha in skeletal muscle results in impaired contractility in female mice.The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice.Therapeutic effects of exon skipping and losartan on skeletal muscle of mdx mice.

P2860

Q27316168-FC66B2BF-ED50-4E3E-983D-5C58792624D7 Q30417474-CCBFC8FA-2AA1-4405-9DDD-820C39A1E628 Q34612572-9A33278B-158E-42DE-BA58-4B1317F10346 Q34625134-1F96A1BB-EAD3-4A3E-8BA1-6304DEC4EC6E Q34771895-271D7A5E-DCBD-4466-8378-A4E93CB11784 Q35108716-400D2AF9-3F42-4448-96C8-5F2C007F3CA9 Q35214216-BD3769E2-FC2E-4AB8-B522-1F11EC258C47 Q35601682-61B90D73-6786-4892-BC51-755701AF5B31 Q36006306-AF218A32-8C18-48F5-B55A-CD2CBBE7BD02 Q36270889-823CF774-1D39-4E2C-9B81-235FA9F862D1 Q36282975-6A59F8D5-3008-4F9E-8528-78C649C196F9 Q36778101-1EBD9F81-24FE-40A6-9430-AE5C51CFF4AD Q36925191-4880A7A8-22FB-4043-BD24-7340E006249B Q36927484-D970C335-8377-4054-B865-F582A4ECDC57 Q37157766-30F1F6FC-8861-420D-AA45-0808B3AC243C Q37494390-C8A5E548-D70B-4A13-BCA3-BD4FDA8D702F Q37711984-79DEE76A-9DE4-412F-A41A-DFB6EB5A4E00 Q38351283-EBDA3DC7-01BD-43EB-868E-579A3FA22437 Q39391006-23B212B8-173C-466F-B238-F321A9629BC5 Q39663447-81F084FC-57CC-4C59-BBDB-1A4A253CF5E8 Q39771895-08F23E7E-C6B0-47C6-844E-F4AC565C556E Q40813682-B619D438-4155-4756-AF90-3B0C4916A25C Q41031903-53173544-4205-4383-837C-499C0B62484F Q42067795-D3031921-455F-452F-BF75-E31C1C15B563 Q42141826-3A33FCC5-0D0F-4FBA-8A90-4500D8144175 Q42234763-A8701D8D-A971-4C6E-B94D-C76BC1D61FDA Q42587467-B886AF36-5F13-4A18-8A73-607842C0A5FC Q44904396-D98E8B7E-E44F-488C-9751-178A6A61CC1D Q44985983-0E619239-07D2-47B4-BA12-4F5A2780102E Q47551802-88A7FCA0-14BB-46B5-9F8C-D8C26621D1B4 Q51625827-07983D88-32D2-45AB-8593-7522943F6B0C Q53263857-2573B2BA-20F5-4B51-92C8-73CC33BE296A

P2860

Effects of prednisolone on skeletal muscle contractility in mdx mice.

http://www.wikidata.org/entity/Q33887318

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@ast

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@en

type

label

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@ast

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@en

prefLabel

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@ast

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@en

P1433

Q33887318-BC579B0C-E24C-4479-884B-8897236E34CD

P1476

Q33887318-0BE1DF15-A4EC-4331-9993-ABA9B952F027

P2093

Q33887318-1A6C09C5-40A1-46D1-A4A3-BC5B5776C3F0

Q33887318-2AF32DD7-104E-488C-89CE-FE9D4E7CB555

Q33887318-4CC5EEC5-7EAE-4C3D-A5EF-506A3FF85BD9

Q33887318-E4413297-5103-414B-B75D-3CDBAFEA5FAF

P2860

Q33887318-03AC44FB-A27B-4341-9A5D-7953BBFE4D78

Q33887318-0E75484E-CB0B-4D1A-82CF-C7D461D3266C

Q33887318-10E79DD8-B359-4029-B67C-96315562F220

Q33887318-133FF5A5-9531-498C-B3DA-9B59AE043FED

Q33887318-1819485A-AEAE-4DF3-B2B7-D52EF652C757

Q33887318-1A8AF1BB-37E8-4D3B-B766-06BBB440F4D2

Q33887318-2AA04662-7FE4-4286-8470-7E5428432AFE

Q33887318-2E367124-F7A9-4688-BBAF-2351DB599302

Q33887318-335A990F-8390-413E-B2D8-36E6ED4476F3

Q33887318-461336C6-51BD-49E7-91B9-E5168CE57F1A

P304

Q33887318-5C8A6388-6296-488E-9BF7-80113622101A

P31

Q33887318-824A9C20-2876-44EF-85F4-EBE7CFE84FFC

P356

Q33887318-AD73505D-50E0-4484-A574-ACDD382A489B

P433

Q33887318-4C1F605C-ECD1-4ADA-A948-3AE953858037

P478

Q33887318-3FC83C85-6688-4100-AFC8-40E6AFBD6892

P577

Q33887318-C4A0A04E-B30F-41CF-BBBB-73906A629F63

P5875

Q33887318-8FDD375B-B19D-47D7-BB44-1F77BCD93544

P698

Q33887318-288B4541-02C5-40E7-8505-99487BC93DA2

P932

Q33887318-413CB9CF-3CE1-41A8-A7EC-B4254E244C7C

P356

P1433

Muscle and Nerve

P1476

Effects of prednisolone on skeletal muscle contractility in mdx mice.

@en

P2093

Dawn A Lowe

http://www.w3.org/2001/XMLSchema#string

Jarrod A Call

http://www.w3.org/2001/XMLSchema#string

Jason B Nikas

http://www.w3.org/2001/XMLSchema#string

Kristen A Baltgalvis

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling

Population frequencies of inherited neuromuscular diseases--a world survey

Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

Adaptive and nonadaptive responses to voluntary wheel running by mdx mice

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

Eccentric contraction-induced injury of mouse soleus muscle: effect of varying [Ca2+]o.

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

P304

443-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.21327

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227756712

http://www.w3.org/2001/XMLSchema#string

P698

19618428

http://www.w3.org/2001/XMLSchema#string

P932

2879072

http://www.w3.org/2001/XMLSchema#string